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Myocardial Revascularization in Two Patients Associated with 
Antiphospholipid Syndrome: Different Pathogenic Patterns and 
Angiographic Results
Samina  Park,  M.D.*,  Ho  Young  Hwang,  M.D.,  Ph.D.*, 
Hyun-Jae  Kang,  M.D.,  Ph.D.**,  Ki-Bong  Kim,  M.D.,  Ph.D.*
We report on two women who underwent myocardial revascularization associated with antiphospholipid syndrome 
(APS) with different pathogenic patterns. The first woman presented with acute myocardial infarction, and pre-
operative angiograms demonstrated rapidly progressing coronary lesions, presumptive unstable plaque, and 
dissection. Operative findings, however, showed fresh thrombi in the coronary arteries, and she was diagnosed 
postoperatively as having APS. Her one-year angiogram demonstrated improved coronary lesions and a competitive 
flow pattern in the grafts. The second woman presented with unstable angina and had been treated for systemic 
lupus erythematosus and secondary APS for more than 14 years. She underwent myocardial revascularization due 
to accelerated coronary atherosclerosis. Her one-year angiogram demonstrated patent grafts.
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CASE REPORT
1) Case 1
A  48-year-old  previously  healthy  woman  visited  our  emer-
gency  department  due  to  intractable  substernal  chest  pain. 
Laboratory  tests  showed  elevated  serum  cardiac  enzymes, 
which  indicated  non-ST  elevation  myocardial  infarction 
(creatine  kinase-MB=14.8  ng/mL,  Troponin  I=3.44  ng/mL). 
She  had  no  risk  factors  for  coronary  artery  disease  including 
a  history  of  smoking,  diabetes  mellitus,  hypertension,  and 
dyslipidemia.  She  did  not  have  a  family  history  of  coronary 
artery disease or gestational morbidity. She had visited anoth-
er  hospital  due  to  chest  pain  8  days  before  admission  to  our 
institution.  A  diagnosis  of  unstable  angina  was  made  and  a 
coronary  angiogram  was  performed,  which  revealed  coronary 
artery  lesions  involving  the  left  anterior  descending  (LAD), 
diagonal,  and  ramus  intermedius  coronary  arteries  (Fig.  1A). 
Her  intractable  chest  pain  persisted  despite  medical  treatment 
including  aspirin  and  the  continuous  infusion  of  heparin  and 
nitroglycerin  by  our  emergency  department.  A  coronary  an-
giogram  was  performed  again  and  demonstrated  aggravated 
coronary  lesions  (Fig.  1B)  and  multiple  luminal  narrowings Samina Park, et al
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Fig. 1. (Case 1) An initial coronary 
angiogram revealed coronary lesions 
in the left anterior descending (LAD, 
black arrow), diagonal (white arrow), 
and ramus intermedius coronary ar-
teries (arrow head) (A). A follow-up 
angiogram taken 8 days later show-
ed aggravated coronary lesions par-
ticularly in the diagonal (white arrow) 
and ramus intermedius coronary ar-
teries (arrow head) (B). An early 
postoperative angiogram showed pat-
ent distal anastomoses (black ar-
rows) (C). A one-year angiogram de-
monstrated completely resolved LAD 
lesions and retrograde visualization 
of the saphenous vein graft from the 
LAD, suggesting a competitive flow 
pattern (black arrow) (D).
even in the left internal thoracic artery (ITA). Because of the 
intractable  chest  pain  associated  with  the  rapidly  progressing 
nature of the coronary lesions, the patient was referred for ur-
gent  myocardial  revascularization.  She  underwent  off-pump 
coronary  artery  bypass  (OPCAB)  using  a  skeletonized  right 
ITA graft as a blood source. The patient was given an initial 
dose of heparin (1.5 mg/kg) and periodically received supple-
mental  doses  to  maintain  an  activated  clotting  time  longer 
than  250  seconds  during  OPCAB.  Because  her  skeletonized 
right  ITA  was  too  short  to  reach  the  target  left  coronary  ar-
teries,  a  segment  of  the  reversed  saphenous  vein  was  anasto-
mosed to the end of the right ITA in an I-fashion and grafted 
to the diagonal and LAD coronary arteries, and the ramus in-
termedius  using  a  sequential  grafting  technique.  Upon  open-
ing  the  coronary  arteries,  the  lumen  was  almost  completely 
filled  with  diffuse  fresh  thrombi.  When  the  fresh  thrombi 
were removed through the coronary arteriotomies, neither cor-
onary  artery  dissection  nor  atherosclerotic  plaque  was  found. 
Protamine was not given at the end of the procedure. The pa-
tient was heparinized in the intensive care unit to maintain an 
activated  clotting  time  longer  than  150  seconds,  and  anti-
coagulation  therapy  using  warfari n  a n d  a s p i r i n  w a s  s t a r t e d  a t  
1  day  postoperatively.  A  angiogram  performed  2  days  post-
operatively demonstrated patent grafts (Fig. 1C). Under a sus-
picion  of  thrombotic  disorder,  laboratory  markers  such  as  lu-
pus  anticoagulant,  anticardiolipin  antibody,  anti-beta2Gp1  an-
tibody,  complement  3,  complement  4,  and  fluorescent  anti-
nuclear antibody, were evaluated postoperatively. She was di-
a g n o s e d  w i t h  A P S  a f t e r  a  p o s i tive  result  for  lupus  anticoa-
gulant.  She  was  discharged  on  the  6th  postoperative  day  on 
warfarin  and  aspirin.  A  1-year  postoperative  angiogram  was 
performed  and  demonstrated  completely  resolved  LAD  le-
s i o n s ,  a  p a t e n t  g r a f t  t o  t h e  r a m u s  i n t e r m e d i u s  a n d  d i a g o n a l  
coronary  arteries,  and  a  competitive  flow  pattern  in  the  graft CABG in Antiphospholipid Syndrome
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Fig. 2. (Case 2) A preoperative cor-
onary angiogram demonstrated totally 
occluded left anterior descending 
(LAD, white arrow) and stenotic ob-
tuse marginal (black arrow) coronary 
arteries (A). A one-year postoperative 
angiogram demonstrated a patent 
Y-composite graft to the coronary ar-
teries (black arrows) (B).
to  the  LAD  coronary  artery  (Fig.  1D).
2 )  C a s e  2    
A 36-year-old woman with a 6-month history of chest pain 
visited our hospital due to chest pain of increasing frequency. 
She  had  been  diagnosed  as  having  systemic  lupus  eryth-
ematosus  (SLE)  at  the  age  of  20,  and  had  been  treated  with 
corticosteroids.  Secondary  APS  manifested  as  recurrent  abor-
t i o n ,  a n  e p i s o d e  o f  a c u t e  p u l m onary  thromboembolism  devel-
oped  2  years  after  the  diagnosis  of  SLE,  and  anticoagulation 
therapy was added. Her family history included an acute my-
ocardial infarction in her elder brother at the age of 34 years. 
Her  electrocardiogram  and  serum  level  of  cardiac  enzymes 
were  normal; however, she did  have a positive treadmill  test. 
A  preoperative  coronary  angiogram  demonstrated  a  com-
pletely  occluded  proximal  LAD  coronary  artery  and  multiple 
stenotic  lesions  in  the  obtuse  marginal  coronary  artery  (Fig. 
2A). She underwent OPCAB  using  skeletonized  bilateral  ITA 
grafts. The right ITA was divided at the proximal section and 
was  anastomosed  in  a  Y-fashion  to  the  side  of  the  left  ITA. 
The  left  ITA  was  anastomosed  to  the  LAD  coronary  artery, 
and  the  right  ITA  was  anastomosed  to  the  diagonal  and  ob-
tuse  marginal  coronary  arteries  in  a  sequential  fashion.  An 
early  angiogram  performed  on  the  1st  postoperative  day  re-
vealed  all  patent  grafts.  She  was  discharged  on  the  7th  post-
operative day on warfarin and aspirin. A 1-year postoperative 
angiogram was performed and demonstrated that all grafts re-
mained  patent  (Fig.  2B). 
DISCUSSION
APS  is  a  clinical  syndrome  associated  with  antibodies 
against phospholipids, and it manifests as systemic thrombotic 
disorders including recurrent deep vein thrombosis, pulmonary 
thromboembolism, brain stroke, and recurrent fetal loss due to 
placental  thrombosis  [1,2].  A  diagnosis  is  made  based  on  at 
least  one  of  the  clinical  features--vascular  thrombosis  and/or 
pregnancy morbidity, and one of the laboratory criteria, which 
are  lupus  anticoagulant  and/or  anticardiolipin  antibody. 
Primary  APS means  that  APS  occurs in  the  absence  of  other 
systemic  autoimmune  disorders.  Otherwise,  secondary  APS  is 
associated  with  an  autoimmune  disorder  such  as  SLE  [3]. 
Coronary  events  have  been  reported  to  occur  in  approx-
imately  5%  of  APS  patients,  particularly  those  under  age  45 
[4]. They are usually associated with accelerated atherosclero-
sis resulting from long-term steroid therapy, dyslipidemia, and 
hypertension  [5,6].  In  addition,  the  presence  of  antiphos-
pholipid  antibody  is  regarded  as  an  independent  risk  factor 
for  premature  atherosclerosis  [4,5].  Coronary  events  tend  to 
occur  secondary  to  other  thrombotic  events  [7].  In  Case  1, 
the  patient previously had  neither risk factors of coronary ar-
tery  disease  nor  clinical  signs  of  APS.  Diffuse  coronary 
thrombosis  imitating  atherosclerotic  coronary  artery  disease 
allowed  us  to  perform  myocardial  revascularization,  like  to  a 
p r e v i o u s  r e p o r t  o f  a  p a t i e n t  w i t h  A P S  a n d  c o r o n a r y  a t h e r o -
sclerosis [8]. We diagnosed the case 1 patient with APS post-
operatively from the intraoperative finding of diffuse coronary 
artery  thrombosis  and  positive  lupus  anticoagulant  activity. Samina Park, et al
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O n  t h e  o t h e r  h a n d ,  t h e  s e c o n d  p a t i e n t  w a s  p r e v i o u s l y  f o l -
lowed  for  secondary  APS.  Severe  atherosclerotic  stenosis  oc-
curred  in  her  left  coronary  artery  territories  despite  long-term 
steroid  and  anticoagulation  therapy.  In  addition  to  the  effect 
of  APS  on  progressive  atherosclerosis,  SLE-induced  my-
ocardial  microvasculopathy  may  have  affected  the  patho-
genesis  of  the  Case  2  patient  [2]. 
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